For the quarter ending 2026-03-31, TRDA has $335,518K in assets. $64,664K in debts. $76,444K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 76,444 | 90,394 | 93,286 | 72,482 |
| Total securities with a maturity of one year or less-One Year Or Less | - | - | 154,920 | - |
| Total securities with a maturity of more than one year-One To Two Years | - | - | 78,632 | - |
| Marketable securities | 178,415 | 205,304 | 233,552 | 281,530 |
| Restricted cash, current portion | 0 | 658 | - | - |
| Collaboration receivable | 787 | 1,177 | 1,196 | 1,180 |
| Prepaid expenses and other current assets | 11,226 | 8,719 | 10,223 | 13,954 |
| Total current assets | 266,872 | 306,252 | 338,257 | 369,146 |
| Property and equipment, net | 6,506 | 7,313 | 8,406 | 9,807 |
| Restricted cash | 3,292 | 3,292 | 3,950 | 3,950 |
| Right-of-use assets, operating leases | 58,758 | 60,451 | 62,122 | 65,681 |
| Other non-current assets | 90 | 70 | 163 | 199 |
| Total assets | 335,518 | 377,378 | 412,898 | 448,783 |
| Accounts payable | 2,930 | 2,289 | 3,166 | 1,857 |
| Accrued expenses and other current liabilities | 11,730 | 17,682 | 15,532 | 11,795 |
| Income taxes payable | - | 0 | 620 | 0 |
| Operating lease obligations, current portion | 4,281 | 4,138 | 4,350 | 5,462 |
| Deferred revenue, current portion | 254 | 342 | 351 | 689 |
| Total current liabilities | 19,195 | 24,451 | 24,019 | 19,803 |
| Operating lease obligations, net of current portion | 45,469 | 46,794 | 48,050 | 49,281 |
| Deferred revenue, net of current portion | - | 0 | 113 | 194 |
| Total liabilities | 64,664 | 71,245 | 72,182 | 69,278 |
| Common stock, par value 0.0001 150,000,000 shares authorized 38,820,616 shares issued and outstanding as of march31, 2026 and 38,284,221 shares issued and outstanding as of december31, 2025 | 4 | 4 | 4 | 4 |
| Additional paidin capital | 583,415 | 578,571 | 574,021 | 568,897 |
| Accumulated other comprehensive income | 246 | 652 | 621 | 400 |
| Accumulated deficit | -312,811 | -273,094 | -233,930 | -189,796 |
| Total stockholders equity | 270,854 | 306,133 | 340,716 | 379,505 |
| Total liabilities and stockholders equity | 335,518 | 377,378 | 412,898 | 448,783 |
Entrada Therapeutics, Inc. (TRDA)
Entrada Therapeutics, Inc. (TRDA)